In conclusion, the results of our study suggest that increased spinal levels of CXCL1, CXCL5, CXCL9, or CXCL12 protein in mice after STZ treatment may participate in the development of diabetic neuropathic pain. This evidence concerns the gene CXCL5 and diabetes mellitus.